CORZIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Nadolol; Bendroflumethiazide.
| Product ID | 60793-284_634fa33e-798d-49ac-b968-9e8b48fa7239 |
| NDC | 60793-284 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CORZIDE |
| Generic Name | Nadolol And Bendroflumethiazide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1983-05-25 |
| Marketing End Date | 2019-10-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018647 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | NADOLOL; BENDROFLUMETHIAZIDE |
| Active Ingredient Strength | 80 mg/1; mg/1 |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 1983-05-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018647 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1983-05-25 |
| Marketing End Date | 2019-10-31 |
| Ingredient | Strength |
|---|---|
| NADOLOL | 80 mg/1 |
| SPL SET ID: | 3f11df27-710b-4903-a985-74ee4674a844 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 60793-283 | CORZIDE | nadolol and bendroflumethiazide |
| 60793-284 | CORZIDE | nadolol and bendroflumethiazide |
| 0115-5311 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
| 0115-5322 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CORZIDE 73256143 1170890 Live/Registered |
E. R. Squibb & Sons Inc. 1980-03-31 |